- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
First Trust IPOX Europe Equity Opportunities ETF(FPXE)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for FPXE
11/20/2026: FPXE (1-star) is currently NOT-A-BUY. Pass it for now.
First Trust IPOX Europe Equity Opportunities ETF (FPXE) provides targeted exposure to the 100 largest and most liquid newly public companies in developed Europe by tracking the IPOX 100 Europe Index. Its main strengths lie in offering a unique, rules-based approach to capturing fresh equity listings that are typically absent from standard indexes, though it features a small asset base, low trading volume, and a higher expense ratio of 0.70%. The fund functions well as a satellite growth allocation for capturing specialized European equity upside. Key risks include elevated market volatility, concentrated sector weights in healthcare and financials, and wider trading bid-ask spreads. It best suits growth-focused investors looking for specialized international diversification while monitoring regional macroeconomic trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The fund focuses on young, newly public growth companies with expansion potential. |
| Momentum investor | Strong fit while signal remains positive | Recent European IPOs frequently display sharp price momentum during supportive market phases. |
| Value investor | Weak fit | IPO valuations often carry premiums that contradict traditional deep-value parameters. |
| Dividend/Income investor | Weak fit | Younger publicly listed firms typically reinvest cash flows rather than distributing high yields. |
| Low-risk investor | Weak fit | Higher volatility and specific exposure to newly listed firms introduce elevated risk. |
Investor Profile
Ideal Investor Profile
Tactical or growth-oriented investors seeking targeted exposure to newly listed European corporations who are comfortable with lower liquidity and a higher expense ratio.
Suitability
Best suited for tactical, long-term satellite allocations rather than core portfolio holdings.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Recently public companies experience sharper price fluctuations than established blue chips. |
| Market risk | High | The fund is fully exposed to systemic downturns in European equity markets. |
| Concentration | Medium / high | Portfolio holdings are constrained to 100 stocks with heavier weightings in sectors like healthcare. |
| Tracking/expense | Medium | A 0.70% expense ratio creates a higher hurdle for outperformance compared to cheap index funds. |
| Liquidity | High | Low assets under management can result in wide bid-ask spreads during market stress. |
| Business/sector quality | Medium | Younger public companies lack long-term operating histories across diverse market cycles. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
FPXE displays elevated historical volatility compared to broad-market European indexes, driven by the higher risk-reward profile of newly public growth companies.
Market Risk
The fund carries substantial equity market and regional European risks, making its returns sensitive to shifts in cross-border market sentiment.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Healthcare Equities | 31.7 | Provides substantial exposure to newly public European biotech and pharmaceutical firms driving innovation. |
| Sector | Financial Services Equities | 21.8 | Offers direct participation in newly listed European banks, asset managers, and fintech platforms. |
| Sector | Consumer Cyclical Equities | 10.4 | Captures consumer discretionary trends and retail growth across European markets. |
| Sector | Industrials Equities | 10 | Involves established European manufacturing, engineering, and capital goods firms coming to market. |
| Sector | Technology & Other Equities | 26.1 | Rounds out the portfolio with emerging tech, energy, basic materials, and telecom listings. |
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 7.9% | Avg. Invested days 54 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

